Researchers are trialling the use of cell therapy used in cancer treatment, in the hope it could offer a possible cure for those with the illness. | ITV National News ...
TRV045 is a novel, highly selective sphingosine-1-phosphate subtype 1 (S1P 1) receptor modulator being developed as a potential treatment for acute and chronic neuropathic pain secondary to diabetic .